Assertio Therapeutics Stock News

LAKE FOREST, Ill., March 02, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT) today announced that it will release fourth quarter and full year 202

Assertio Holdings Inc. (NASDAQ:ASRT) concluded the trading at $2.37 on Friday, February 25 with a rise of 3.95% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $2.28 and 5Y monthly beta was reading 1.66 with its price kept floating in the … Assertio Holdings Inc. (ASRT) Worth Considering For The Next Few Weeks Read More »

An investigation on behalf of investors in Assertio Holdings, Inc. (NASDAQ: ASRT) shares over potential wrongdoing at Assertio Holdings, Inc. was announced. San Diego, CA -- ( SBWIRE ) -- 02/25/2022 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Assertio Holdings, Inc. Investors who purchased shares of Assertio Holdings, Inc. (NASDAQ: ASRT) have certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Assertio Holdings directors breached their fiduciary duties and caused damage to the company and its shareholders. Lake Forest, IL based Assertio Holdings, Inc., a commercial pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Assertio Holdings, Inc. reported that its annual Total Revenue declined from $229.5 million in 2019 to $106.27 million in 2020, and that its Net Loss declined from $217.2 million in 2019 to $28.14 million in 2020.

Here is how Assertio (ASRT) and Homology Medicines (FIXX) have performed compared to their sector so far this year.

Assertio Holdings Inc. (NASDAQ:ASRT) price on Friday, February 11, fall -5.26% below its previous days close as a downside momentum from buyers pushed the stocks value to $2.52. A look at the stocks price movement, the close in the last trading session was $2.66, moving within a range at $2.50 and $2.72. The beta value Is Assertio Holdings Inc. (NASDAQ: ASRT) A Top Momentum Pick? Read More »

NEW YORK , Jan. 24, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for EXTN, MBOT, JWN, TEF, and ASRT. Full story available on Benzinga.com

After years of losses and declining revenues, new management was brought in a year ago. Assertio looks almost entirely different than two years ago.

Assertio's Digital Strategy Looks To Be Paying Off

LAKE FOREST, Ill., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. ("Assertio" or "the Company") (NASDAQ: ASRT ) today announced that the Company''s Chief Executive Officer, Dan Peisert, and Chief Financial Officer, Paul Schwichtenberg, will participate in the H.C. Wainwright BioConnect Virtual Conference scheduled to take place from Monday, January 10 through Thursday, January 13, 2022. The Company''s investor presentation is now available for on-demand viewing on the Assertio Investor Relations website and will remain available on the Latest Events page for approximately 30 days following the presentation. To access the webcast and for more information about Assertio, please visit https://investor.assertiotx.com/overview/default.aspx . About Assertio Assertio is a leading commercial pharmaceutical company bringing differentiated products to patients. The Company has a robust portfolio of branded prescription products in three areas: neurology, hospital, and pain and inflammation.

Here is how Assertio (ASRT) and Amphastar Pharmaceuticals (AMPH) have performed compared to their sector so far this year.

Assertio Holdings Inc (ASRT) shares closed this week 24.3% higher than it did at the end of last week. The stock is currently up 24.3% year-to-date, up 25.7% over the past 12 months, and down 24.7% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%. Trading Activity Shares traded as high as $2.82 and as low as $2.18 this week.Shares closed 53.3% below its 52-week high and 218.4% above its 52-week low.Trading volume this week was 63.4% lower than the 10-day average and 63.9% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.9. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -662.5% The company's stock price performance over the past 12 months beats the peer average by -237.6% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Assertio Holdings Inc (ASRT) shares closed today 12.4% higher than it did at the end of yesterday. The stock is currently up 24.3% year-to-date, up 25.7% over the past 12 months, and down 24.7% over the past five years. Today, the Dow Jones Industrial Average fell 0.0%, and the S&P 500 fell 0.4%. Trading Activity Shares traded as high as $2.82 and as low as $2.18 this week.Shares closed 53.3% below its 52-week high and 218.4% above its 52-week low.Trading volume this week was 63.4% lower than the 10-day average and 63.9% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.9. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price beats the S&P 500 Index today, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, beats it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -662.5% The company's stock price performance over the past 12 months beats the peer average by -237.6% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Assertio Holdings Inc (ASRT) shares closed today 12.4% higher than it did at the end of yesterday. The stock is currently up 24.3% year-to-date, up 37.3% over the past 12 months, and down 24.7% over the past five years. Today, the Dow Jones Industrial Average fell 0.0%, and the S&P 500 fell 0.4%. Trading Activity Shares traded as high as $2.82 and as low as $2.18 this week.Shares closed 53.3% below its 52-week high and 218.4% above its 52-week low.Trading volume this week was 63.6% lower than the 10-day average and 62.4% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.9. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 5.6% higher than its 5-day moving average, 32.4% higher than its 20-day moving average, and 102.1% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index today, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, beats it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -662.5% The company's stock price performance over the past 12 months beats the peer average by -295.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.